Video

Obesity's Role in the Treatment and Development of Disease

Obesity was a common theme at RNS16 this year in which speakers touched on obesity as a cause of disease onset and even as one that can prevent therapeutic treatments from working.

Obesity was a common theme amongst talks given at the recent Rheumatology Nurses Society annual conference held in Cleveland earlier this month. Obesity can lead to disease onset, it can exasperate existing conditions and even prevent therapeutic treatments from working. 

Christopher Ritchlin, M.D., of University of Rochester Medical School, and a specialist in psoriatic arthritis addresses the issue of obesity in this soundbite. The issue, though, comes down to teamwork that involves the patient and a team of healthcare professionals.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.